Telkom Divests AdMedika to Fullerton Health in Strategic Digital Pivot

JAKARTA, Indonesia – March 09, 2026 – In a significant strategic realignment, PT Telkom Indonesia (TelkomGroup) has moved to divest its healthcare administration arm, PT Administrasi Medika (AdMedika), to the regional healthcare giant Fullerton Health. The deal, formalized through a Conditional Share Purchase Agreement (CSPA) on March 4, 2026, marks a pivotal moment for all parties involved, signaling Telkom's sharpened focus on its core digital and telecommunications business while positioning AdMedika for a new phase of regional growth.

The agreement, signed between Telkom's subsidiary PT Multimedia Nusantara (TelkomMetra) and Fullerton Health, will see the transfer of the entire AdMedika Group, including its subsidiary TelkoMedika. While the final financial terms have not been publicly disclosed, earlier reports from mid-2025 suggested the deal could value AdMedika at up to IDR 1.62 trillion (approximately US$100 million), a substantial increase from TelkomMetra's initial acquisition of a 75% stake in 2010 for IDR 128.25 billion.

This divestment is a calculated move under Telkom's 'TLKM 30' transformation program, which aligns with a broader state-owned enterprise (SOE) streamlining agenda mandated by the government. For AdMedika, Indonesia's largest third-party administrator (TPA), the acquisition by a specialized healthcare player promises access to new markets and technological expertise.

Telkom's Calculated Retreat to its Core

The sale of AdMedika is a clear indicator of TelkomGroup's commitment to portfolio optimization. As a state-owned telecommunications behemoth, its long-term strategy involves shedding non-core assets to concentrate resources and capital on its primary domains: digital services, data centers, and telecommunications infrastructure. The Indonesian Ministry of SOE has previously highlighted Telkom as a model for effective restructuring among state-owned entities, and this divestiture serves as a prime example of that strategy in action.

AdMedika, while a leader in its field, operates in the health-tech and insurance services sector, a field increasingly distant from Telkom's central mission. The decision to divest was described as a carefully considered step to unlock greater value and ensure AdMedika's future growth under a more strategically aligned parent company.

Pramasaleh Haryo Utomo, President Director of TelkomMetra, underscored the strategic rationale behind the sale. "The signing of the CSPA with Fullerton Health, which marks a step toward the full divestment of AdMedika Group, is a carefully measured decision made by upholding the principles of Good Corporate Governance, based on comprehensive business considerations, and aligned with TelkomGroup's transformation to strengthen its focus on the core business and to create long-term value," he stated.

This move is not an isolated event but part of a consistent pattern. It follows other strategic restructuring efforts by Telkom, such as the spin-off of its telecommunication tower subsidiary, Mitratel. By pruning its portfolio, Telkom aims to become a more agile and focused entity, better equipped to compete in the rapidly evolving global digital landscape.

Fullerton Health's Bold Indonesian Expansion

For Fullerton Health, the acquisition of AdMedika is a major strategic victory, significantly deepening its footprint in Southeast Asia's largest economy. As a leading integrated healthcare solutions provider with operations across nine Asia-Pacific markets, Fullerton Health views Indonesia as a critical growth engine. The group already manages a vast network of approximately 550 healthcare facilities and partners with over 20,000 providers, serving more than 26,000 corporate clients.

This acquisition follows a well-established pattern of regional expansion through strategic M&A. Fullerton Health has previously expanded its reach with key acquisitions in the Philippines, Australia, and Singapore. For instance, its 2018 acquisition of two HMO companies in the Philippines and its 2017 majority stake in Intellicare demonstrated a clear intent to dominate the managed care and TPA space across the region. The AdMedika deal is its most significant move in Indonesia to date.

Ho Kuen Loon, Group CEO of Fullerton Health, highlighted the synergy between the two organizations. "This acquisition reflects Fullerton Health's commitment to strengthening our presence and contribution to Indonesia's healthcare landscape. AdMedika Group has been thoughtfully developed within the TelkomGroup into a trusted and highly comprehensive healthcare administration platform, built on strong governance, digital innovation and clinical discipline. These qualities closely align with our own capabilities and values," he said. "We see this acquisition as an important step toward expanding access to high quality healthcare for the people of Indonesia and across the region."

By integrating AdMedika's market-leading TPA network, Fullerton Health not only gains immediate scale in Indonesia but also a robust platform to deploy its own digital health technologies and managed care expertise.

Reshaping Indonesia's Healthcare Administration

The combination of AdMedika's dominant local presence with Fullerton Health's regional scale and expertise is poised to reshape Indonesia's healthcare administration landscape. AdMedika already holds the position of the largest TPA in the country, providing essential claims management and health services to a vast network of corporations and insurance companies. The backing of Fullerton Health is expected to accelerate its trajectory.

The synergy promises significant benefits for the Indonesian market. Corporate clients can anticipate more sophisticated, integrated healthcare solutions that leverage Fullerton's global best practices and technological platforms. For patients, the merger could lead to a more seamless healthcare experience, with improved access to a wider network of providers and more advanced digital health tools.

This move comes at a time of increasing competition and a drive for digitalization within the Indonesian healthcare and insurance industries. The new, larger entity will be better positioned to invest in the technology and innovation required to meet the evolving needs of the market. The integration is expected to create a formidable competitor, potentially spurring further consolidation and innovation among other players in the TPA sector.

Ultimately, the fusion of AdMedika's local foundation with Fullerton Health's regional capabilities is designed to create a more effective and scalable platform. This will not only reinforce AdMedika's leadership in Indonesia but also create clear pathways for its future expansion into the wider Southeast Asian region, leveraging Fullerton Health's extensive network.